{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:45:20Z","timestamp":1788356720968,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Objective: To establish and validate a comprehensive predictive model combining clinical data and radiomics features to improve the accuracy of predicting recurrence within five years after surgery in patients with non-functioning pituitary macroadenomas (NFMA). Methods: This retrospective study included 292 NFMA patients who underwent surgery between January 2012 and January 2018, with an additional 123 patients as an external test set. Clinical, pathological, and conventional imaging features were collected and analyzed using univariate and multivariate logistic regression to identify independent risk factors for postoperative recurrence. Radiomic features were extracted from preoperative T1-weighted (T1WI), T2-weighted (T2WI), and T1-enhanced images using 3D Slicer software. A radiomics prediction model was developed, and a combined model integrating clinical and radiomics features was established. The predictive performance of the models was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). Results: The clinical model (Cli-score), radiomics model (Rad-score) and combined model were developed. The diagnostic performance of the clinical model in the external test set, showed an AUC of 0.757 (95%CI: 0.671\u20130.830), with SEN, SPE, and ACC of 82.5%, 59.04%, and 71.54%, respectively. The diagnostic performance of the radiomics model in the external test set showed an AUC of 0.835 (95% CI: 0.757\u20130.896), with 80%, 79.52% and 63.41% for SEN, SPE and ACC%, respectively. The diagnostic performance of the combined model in the external test set showed an AUC of 0.863 (95% CI: 0.790\u20130.919), with SEN, SPE, and ACC of 80%, 81.93%, and 68.30%, respectively. The calibration curve indicated good predictive performance, and DCA confirmed the high clinical utility of the combined model. Conclusion: The combined model provides a more accurate prediction of NFMA recurrence. This model can guide postoperative follow-up strategies and aid in early initiation of adjuvant therapy for high-risk patients.<\/jats:p>","DOI":"10.1038\/s41598-025-89907-z","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:28:16Z","timestamp":1744644496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["MRI based radiomics nomogram for predict recurrence of non functioning pituitary macroadenomas post surgery"],"prefix":"10.1038","volume":"15","author":[{"given":"Ji-ping","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-zhi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-xiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-jie","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"5","key":"89907_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrendo.2011.40","volume":"7","author":"S Melmed","year":"2011","unstructured":"Melmed, S. Pathogenesis of pituitary tumors. Nat. Rev. Endocrinol. 7 (5), 257\u2013266 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"89907_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12022-014-9322-y","volume":"25","author":"J Trouillas","year":"2014","unstructured":"Trouillas, J. In search of a prognostic classification of endocrine pituitary tumors. Endocr. Pathol. 25 (2), 124\u2013132 (2014).","journal-title":"Endocr. Pathol."},{"issue":"1","key":"89907_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ecl.2014.10.001","volume":"44","author":"G Raverot","year":"2015","unstructured":"Raverot, G. et al. A prognostic clinicopathologic classification of pituitary endocrine tumors. Endocrinol. Metab. Clin. North. Am. 44 (1), 11\u201318 (2015).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"4","key":"89907_CR4","doi-asserted-by":"publisher","first-page":"R121","DOI":"10.1530\/EJE-13-1031","volume":"170","author":"G Raverot","year":"2014","unstructured":"Raverot, G., Jouanneau, E. & Trouillas, J. Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies. Eur. J. Endocrinol. 170 (4), R121\u2013R132 (2014).","journal-title":"Eur. J. Endocrinol."},{"key":"89907_CR5","doi-asserted-by":"crossref","unstructured":"Molitch, M. E. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol. Metab. Clin. N. Am.  37(1), 151\u2013171 (2008) .","DOI":"10.1016\/j.ecl.2007.10.011"},{"issue":"5","key":"89907_CR6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4103\/0028-3886.86543","volume":"59","author":"E Roldan-Valadez","year":"2011","unstructured":"Roldan-Valadez, E. et al. 3D volumetry comparison using 3T magnetic resonance imaging between normal and adenoma-containing pituitary glands. Neurol. India. 59 (5), 696\u2013699 (2011).","journal-title":"Neurol. India"},{"key":"89907_CR7","doi-asserted-by":"crossref","unstructured":"Roelfsema, F., Biermasz, N. R. & Pereira, A. M. Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: A structured review and meta-analysis. Pituit 15(1), 71\u201383 (2012) .","DOI":"10.1007\/s11102-011-0347-7"},{"key":"89907_CR8","unstructured":"Chen, Y. et al. Natural History of Postoperative Nonfunctioning Pituitary Adenomas: A Systematic Review and Meta-Analysis. 96333\u201396342 (Neuroendocrinology, 2012)."},{"key":"89907_CR9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jocn.2017.07.015","volume":"44","author":"M Karki","year":"2017","unstructured":"Karki, M. et al. Large and giant pituitary adenoma resection by microscopic trans-sphenoidal surgery: Surgical outcomes and complications in 123 consecutive patients. J. Clin. Neurosci. 44, 310\u2013314 (2017).","journal-title":"J. Clin. Neurosci."},{"key":"89907_CR10","doi-asserted-by":"crossref","unstructured":"Snead, F.E. et al. Long-term outcomes of radiotherapy for pituitary adenomas. Int. J. Radiat. Oncol. Biol. Phys. 71 (4), 994\u2013998 (2008).","DOI":"10.1016\/j.ijrobp.2007.11.057"},{"issue":"4","key":"89907_CR11","first-page":"323","volume":"11","author":"C Das","year":"2019","unstructured":"Das, C. et al. Evaluation of prognostic utility of Ki-67, P53, and O-6-methylguanine-DNA methyltransferase expression in pituitary tumors. J. Lab. Phys. 11 (4), 323\u2013329 (2019).","journal-title":"J. Lab. Phys."},{"issue":"3","key":"89907_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3171\/JNS\/2008\/108\/3\/0525","volume":"108","author":"M Losa","year":"2008","unstructured":"Losa, M. et al. Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J. Neurosurg. 108 (3), 525\u2013532 (2008).","journal-title":"J. Neurosurg."},{"issue":"2","key":"89907_CR13","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s10143-021-01662-7","volume":"45","author":"CC Ko","year":"2021","unstructured":"Ko, C. C. et al. Solid tumor size for prediction of recurrence in large and giant non-functioning pituitary adenomas. Neurosurg. Rev. 45 (2), 1401\u20131411 (2021).","journal-title":"Neurosurg. Rev."},{"key":"89907_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin, P. et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur. J. Cancer. 48, 441\u2013446 (2012).","journal-title":"Eur. J. Cancer"},{"key":"89907_CR15","unstructured":"Ugga, L. et al. Prediction of High Proliferative Index in Pituitary Macroadenomas Using MRI-Based Radiomics and Machine Learning. 611365\u2013611373 (Neuroradiology, 2019)."},{"key":"89907_CR16","doi-asserted-by":"crossref","unstructured":"Shen, C. et al. A novel magnetic resonance imaging-based radiomics and clinical predictive model for the regrowth of postoperative residual tumor in non-functioning pituitary neuroendocrine tumor. Medicina 59(9),  1525 (2023) .","DOI":"10.3390\/medicina59091525"},{"key":"89907_CR17","doi-asserted-by":"publisher","first-page":"590083","DOI":"10.3389\/fonc.2020.590083","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Radiomics approach for prediction of recurrence in nonfunctioning pituitary macroadenomas. Front. Oncol. 10, 590083 (2020).","journal-title":"Front. Oncol."},{"key":"89907_CR18","doi-asserted-by":"crossref","unstructured":"Vickers, A. J. et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med. Inf. Decis. Mak. 8, 53 (2008).","DOI":"10.1186\/1472-6947-8-53"},{"key":"89907_CR19","doi-asserted-by":"crossref","unstructured":"Molitch, M. E. Diagnosis and treatment of pituitary adenomas: A review. JAMA 317(5), 516524 ( 2017).","DOI":"10.1001\/jama.2016.19699"},{"key":"89907_CR20","doi-asserted-by":"crossref","unstructured":"Bonneville, J. F. Magnetic resonance imaging of pituitary tumors. Front. Horm. Res. 45, 97120 (2016).","DOI":"10.1159\/000442327"},{"key":"89907_CR21","doi-asserted-by":"publisher","first-page":"e118e124","DOI":"10.1016\/j.wneu.2018.07.056","volume":"119","author":"W Saeger","year":"2018","unstructured":"Saeger, W. et al. Recurrences of pituitary adenomas or second de novo tumors: comparisons with first tumors. World Neurosurg. 119, e118e124 (2018).","journal-title":"World Neurosurg."},{"issue":"2","key":"89907_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3171\/2018.10.JNS181783","volume":"132","author":"CC Ko","year":"2019","unstructured":"Ko, C. C. et al. Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging. J. Neurosurg. 132 (2), 351\u2013359 (2019).","journal-title":"J. Neurosurg."},{"key":"89907_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas, J. et al. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years postoperative follow-up. Acta Neuropathol. 126, 123\u2013135 (2013).","journal-title":"Acta Neuropathol."},{"key":"89907_CR24","doi-asserted-by":"crossref","unstructured":"Lv, L. et al. Clinical and pathologic characteristics predicted the postoperative recurrence and progression of pituitary adenoma: A retrospective study with 10 years follow-up. World Neurosurg. 118, e428\u2013e435 (2018).","DOI":"10.1016\/j.wneu.2018.06.210"},{"issue":"1","key":"89907_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cen.14197","volume":"93","author":"F Guaraldi","year":"2020","unstructured":"Guaraldi, F. et al. A practical algorithm to predict postsurgical recurrence and progression of pituitary neuroendocrine tumours (PitNET)s. Clin. Endocrinol. (Oxf). 93 (1), 36\u201343 (2020).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"89907_CR26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2265.2009.03583.x","volume":"71","author":"EP O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan, E. P. et al. The natural history of surgically treated but radiotherapy-na\u00efve nonfunctioning pituitary adenomas. Clin. Endocrinol. 71, 709\u2013714 (2009).","journal-title":"Clin. Endocrinol."},{"key":"89907_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1530\/eje.1.02298","volume":"155","author":"E Ferrante","year":"2006","unstructured":"Ferrante, E. et al. Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur. J. Endocrinol. 155, 823\u2013829 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"89907_CR28","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1210\/jc.2005-2552","volume":"91","author":"OM Dekkers","year":"2006","unstructured":"Dekkers, O. M. et al. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J. Clin. Endocrinol. Metab. 91, 1796\u20131801 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"89907_CR29","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncology 23, 1231\u20131251 (2021).","journal-title":"Neuro-Oncology"},{"key":"89907_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/EJE-18-0749","volume":"180","author":"S Asioli","year":"2019","unstructured":"Asioli, S. et al. Validation of a clinicopathological score for the prediction of postsurgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre. Eur. J. Endocrinol. 180, 127\u2013134 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"89907_CR31","first-page":"1","volume":"27","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Ki-67 labeling index and knosp classification of pituitary adenomas. Br. J. Neurosurg. 27, 1\u20135 (2021).","journal-title":"Br. J. Neurosurg."},{"key":"89907_CR32","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.4103\/0028-3886.287675","volume":"68","author":"JP Almeida","year":"2020","unstructured":"Almeida, J. P. et al. The importance of long-term follow-up after endoscopic pituitary surgery: durability of results and tumor recurrence. Neurol. India. 68, S92\u2013S100 (2020).","journal-title":"Neurol. India"},{"key":"89907_CR33","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.ando.2016.02.004","volume":"77","author":"X Zheng","year":"2016","unstructured":"Zheng, X. et al. Current biomarkers of invasive sporadic pituitary adenomas. Ann. Endocrinol. 77, 658\u2013667 (2016).","journal-title":"Ann. Endocrinol."},{"key":"89907_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s11102-019-00982-8","volume":"22","author":"AL Pappy","year":"2019","unstructured":"Pappy, A. L. et al. Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients. Pituitary 22, 520\u2013531 (2019).","journal-title":"Pituitary"},{"key":"89907_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.21037\/gs-21-47","volume":"10","author":"W Lyu","year":"2021","unstructured":"Lyu, W. et al. Nomogram predictive model of post-operative recurrence in non-functioning pituitary adenoma. Gland Surg. 10, 807\u2013815 (2021).","journal-title":"Gland Surg."},{"key":"89907_CR36","doi-asserted-by":"publisher","first-page":"793337","DOI":"10.3389\/fendo.2021.793337","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Analysis of related factors of tumor recurrence or progression after transnasal sphenoidal surgical treatment of large and giant pituitary adenomas and establish a nomogram to predict tumor prognosis. Front. Endocrinol. 12, 793337 (2021).","journal-title":"Front. Endocrinol."},{"key":"89907_CR37","doi-asserted-by":"crossref","unstructured":"Balachandran, V. P. et al. Nomograms in oncology: More than meets the eye. Lancet Oncol. 16, e173\u2013e180 (2015).","DOI":"10.1016\/S1470-2045(14)71116-7"},{"key":"89907_CR38","doi-asserted-by":"crossref","unstructured":"Lu, L. et al. Development and validation of a prognostic model: Post-operative recurrence of pituitary adenomas.  Front. Oncol. 28(12), 882049 (2022) .","DOI":"10.3389\/fonc.2022.882049"},{"key":"89907_CR39","doi-asserted-by":"publisher","first-page":"103966","DOI":"10.1016\/j.compbiomed.2020.103966","volume":"124","author":"LF Machado","year":"2020","unstructured":"Machado, L. F. et al. MRI radiomics for the prediction of recurrence in patients with clinically non-functioning pituitary macroadenomas. Comput. Biol. Med. 124, 103966 (2020).","journal-title":"Comput. Biol. Med."},{"key":"89907_CR40","doi-asserted-by":"publisher","first-page":"780628","DOI":"10.3389\/fneur.2021.780628","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. A preoperative MRI-based radiomics-clinicopathological classifier to predict the recurrence of pituitary macroadenoma within 5 years. Front. Neurol. 12, 780628 (2022).","journal-title":"Front. Neurol."},{"key":"89907_CR41","doi-asserted-by":"publisher","first-page":"813806","DOI":"10.3389\/fonc.2022.813806","volume":"12","author":"YJ Chen","year":"2022","unstructured":"Chen, Y. J. et al. Deep learning for prediction of progression and recurrence in nonfunctioning pituitary macroadenomas: combination of clinical and MRI features. Front. Oncol. 12, 813806 (2022).","journal-title":"Front. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89907-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89907-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89907-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:28:23Z","timestamp":1744644503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89907-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89907"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89907-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethics Committee of Affiliated Hospital of Qingdao University approved the study and waived the need of informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"12841"}}